Every year, more than one million scientific articles are published in the life sciences. Two-thirds of them include ...

AI tools that provide information to you also gather lots of information from you and may provide it to third parties.

Built around our customers’ preferred data foundation, powered by our award-winning Domo.AI solution, and enriched with our partner ecosystem, the Domo platform enables users to prepare ...

During the 85th Scientific Sessions, Lexicon also will present topline data from its PROGRESS Phase 2b study evaluating pilavapadin (LX9211) in adults with diabetic peripheral neuropathic pain.

Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL Data reported from the ...

Lexicon Pharmaceuticals announced that it will present data from a study on sotagliflozin's effects on hypoglycemia in individuals with type 1 diabetes at the upcoming American Diabetes ...

REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics ("Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers ...

Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions Provided by GlobeNewswire Jun 17, 2025, 4:00:00 AM ...

There are few things more tragic in life than watching a middle-aged man try to look enthused during a corporate upskilling workshop on Artificial Intelligence. Politely nodding practised expressions ...

In a session entitled "Interventions to Prevent Hypoglycemia: Bench to Bedside,” Lexicon US Medical Affairs team member M. Belinda Hardin, PharmD, BCPS, will present sotagliflozin clinical efficacy ...

MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), will present results ...

Skye Bioscience was selected to present new data on nimacimab at the prestigious American Diabetes Association’s 85th Scientific Sessions, indicating recognition and credibility in the research ...